Small cap
Laxmi Organic's logistics costs doubled as Red Sea crisis hit Q4
Sequential revenue rose 9-10% but full-year sales fell 6%. Management won't guide for FY27-28, citing chemical-price volatility.
Shanti Gold's FY26 profit jumped 159%. The press release adds nothing.
The audited results show strong growth, but the market already knew. This is a summary, not a surprise.
SKM Egg bets ₹410 cr on quadrupling egg output
The micro-cap plans a fourfold capacity jump in laying birds, financed by a ₹302 cr term loan. It’s also buying out a marketing associate.
Venus Remedies gets first global approval for oncology drug in Saudi Arabia
The Saudi FDA's nod for Plerixafor lets Venus move from commodity drugs into higher-value oncology. Saudi Arabia is the largest Gulf pharma market.
Greenpanel guided cautiously after Q4, but the market already knew.
The Q4 FY26 earnings transcript confirms the live-call details: volume growth, a 15% price hike, and Middle East export issues. Nothing new.
SPML Infra lands ₹165.4 cr order from Rajasthan power utility
The Kota substation contract is worth about 10% of SPML's market cap and adds to a large NTPC battery-storage win secured earlier this year.
Laxmi Dental hits record revenue, then pulls FY27 guidance
A strong Q4 was immediately overshadowed by management's refusal to reaffirm profit targets, after missing FY26 margin guidance.
NGL Fine-Chem profit jumps 128% as India revenue more than doubles
Consolidated net profit surged to ₹48.13 crore in FY26, outpacing a 36% rise in revenue to ₹500.95 crore on broad-based demand.
NGL Fine-Chem profit more than doubles to ₹48 cr on broad-based demand
Consolidated revenue rose 36% for the full year, with domestic sales more than doubling and rest-of-world surging 78%.
Ashoka Buildcon's weak quarter is paired with ₹1,136 cr Maharashtra IT order
Q4 standalone profit fell 18%, but the company announced new orders including a ₹1,136 cr state modernisation contract.
Wakefit's raw material bill jumped 160%. It will take a margin hit to keep growing.
CEO Ankit Garg said the company will sacrifice 1-2% of EBITDA margin to defend 20% revenue growth. The inflation is real.
Euro Pratik promoters bought ₹35 cr of stock in two days
The promoter group picked up 1.26% of equity through open-market purchases on May 19 and 20, the third open-market buy this year.
Sharda Motor lands ₹530 cr in new orders from four OEMs
The orders, from global and domestic manufacturers, lift the auto-component maker's order book. Full-year revenue hit ₹3,397 cr, up 20%.
Samhi shifts Rare India's Marriott brand, delays GST normalization by two quarters
The hotel company has moved its recent acquisition to Marriott's Autograph Collection from the Outdoor Collection, and now expects GST headwinds to fade in Q3 FY27, not Q1.
Vaibhav Global's Q4 presentation adds detail but no new numbers
The investor deck supplements already-announced results. It carries segment data and brand commentary, nothing the market hasn't already priced.
Vaibhav Global's margins hit double digits for the first time in three years
A strong Q4 showed revenue up 10%, EBITDA up 36%, and in-house brands hitting their target a year early. The German unit turned profitable.
Laxmi Dental re-announces audited Q4 and FY26 results it already filed.
A routine press release adds management narrative to numbers that are already public. The event was the earlier filing.
Ashoka Buildcon's ₹2,576 cr profit hides shrinking core earnings
Consolidated PAT surged on subsidiary sale gains. Excluding those, underlying profit declined.
Ashoka Buildcon's FY26 profit is mostly one-off gains, not core business
Consolidated PAT jumped 49% to ₹2,576 cr, but ₹2,144 cr came from subsidiary sales. Excluding those, profit fell.
Flair Writing reports FY26 revenue of ₹1,250 cr. The numbers aren't new.
The company's press release is a detailed narrative for results already announced. PAT grew 18.7% to ₹141.3 crore, matching its prior guidance.
Laxmi Dental posts 22% revenue growth, but a new labour-law charge hits profit
Standalone profit fell after a ₹51.6 cr exceptional charge for gratuity costs. Revenue and underlying profit both grew strongly.
Laxmi Organic files FY26 results, but there's nothing left to say.
The board formally approved audited numbers, a dividend, and a CFO appointment that the market already knew.
Wakefit swings to profit on tax gain, but core earnings story is quieter
A ₹980.7M deferred tax asset drove the Q4 bottom line. Strip that out, and the turnaround is slower than the headline suggests.
NGL Fine-Chem profit jumps 128% on strong domestic and export demand
Consolidated revenue rose 36% to ₹500.95 crore, while India sales more than doubled, lifting net profit to ₹48.13 crore.
Kesar India wins ₹160 cr Zee contract, nearly the size of its entire revenue
The Byculla residential project equals about 90% of Kesar India's last full-year revenue. Execution spans 24 months.